Atlas Trials

Hanlim Pharm. Co., Ltd.

50 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Hanlim Pharm. Co., Ltd.

RecordFirmDate
Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting State (NCT07568652)Hanlim Pharm. Co., Ltd.2024-10-16
Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects. (NCT06642987)Hanlim Pharm. Co., Ltd.2023-10-23
Evaluation of the Clinical Efficacy and Safety of BriTurn Injection or BrisTurn Prefilled Injection (NCT06246331)Hanlim Pharm. Co., Ltd.2023-07-21
Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult Volunteers (NCT07598968)Hanlim Pharm. Co., Ltd.2023-06-18
Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease (NCT06434792)Hanlim Pharm. Co., Ltd.2023-06-01
S-amlodipine in Essential HypertensIon and Assessment of Blood Pressure Targets Achievement (NCT06130124)Hanlim Pharm. Co., Ltd.2023-02-22
Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops (NCT06172530)Hanlim Pharm. Co., Ltd.2023-02-08
The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab (NCT06188234)Hanlim Pharm. Co., Ltd.2022-12-27
Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy (NCT05358080)Hanlim Pharm. Co., Ltd.2022-05-27
DEXINEURO® Tab on Blood Glucose Reduction in Patients With Type 2 Diabetes Accompanied by Diabetic Peripheral Neuropathy (NCT06191614)Hanlim Pharm. Co., Ltd.2022-05-19
An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine) (NCT06214832)Hanlim Pharm. Co., Ltd.2021-11-11
An Observational Study on the Identification of Prescription Patterns of STAFEN Cap (NCT06204380)Hanlim Pharm. Co., Ltd.2021-04-21
Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD) (NCT04882228)Hanlim Pharm. Co., Ltd.2021-01-28
Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients (NCT04632342)Hanlim Pharm. Co., Ltd.2020-11-01
Phase 2a Clinical Trial of HL237 for Rheumatoid Arthritis (NCT04638426)Hanlim Pharm. Co., Ltd.2020-09-10
To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia (NCT04659070)Hanlim Pharm. Co., Ltd.2020-07-15
Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers (NCT04667624)Hanlim Pharm. Co., Ltd.2020-02-29
Study to Evaluate HL-TOF Tab. 5 mg Compared With XelJanz Tab. in Healthy Volunteers (NCT04114461)Hanlim Pharm. Co., Ltd.2019-11-06
A Multiple Dose of HL237 in Healthy Male Subject (NCT03896594)Hanlim Pharm. Co., Ltd.2018-12-24
To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions (NCT03743259)Hanlim Pharm. Co., Ltd.2018-05-29
A Dose-escalation Clinical Trial After Multiple Dosing of HL217 Eye Drop in Healthy Male Subjects (NCT03648346)Hanlim Pharm. Co., Ltd.2018-04-04
A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients (NCT03654196)Hanlim Pharm. Co., Ltd.2018-03-16

Track Hanlim Pharm. Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.